BiotechTube
RTLGenomics

RTLGenomics

Lubbock, United States· Est.
rtlgenomics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

RTLGenomics is an established, full-service NGS laboratory with nearly two decades of experience, offering end-to-end solutions from sample to data analysis. The company leverages cutting-edge Illumina and PacBio platforms to deliver customized, high-quality sequencing services with a strong emphasis on bioinformatics support. Acquired by its sister company MicroGen Diagnostics in 2020, it has expanded its technical capabilities and resources while maintaining a strong track record evidenced by thousands of peer-reviewed publications. Its business model is centered on providing contract research services to the life sciences sector.

Genetics & GenomicsDiagnostics

Technology Platform

Full-service NGS laboratory utilizing Illumina (MiSeq, NovaSeq 6000) and PacBio (Sequel IIe) sequencing platforms, coupled with a proprietary bioinformatics and biostatistics analysis suite.

Opportunities

The growing global demand for outsourced NGS and bioinformatics services, particularly in microbiome research and complex genomics, presents a significant expansion opportunity.
Synergies with its parent company, MicroGen Diagnostics, could enable entry into clinical diagnostic sequencing markets.
The continued development of more sophisticated, multi-omics bioinformatics services offers a path to higher-value offerings.

Risk Factors

The company faces intense competition in the NGS services market and risks from rapid technological obsolescence requiring constant capital investment.
Its operational model is dependent on key platform providers (Illumina, PacBio) for technology and reagents.
Research funding cycles and economic conditions can create volatility in demand from its core academic and government client base.

Competitive Landscape

RTLGenomics competes in a fragmented market against university core facilities, large global CROs (e.g., Eurofins, Azenta), and specialized sequencing service providers. Its differentiation lies in its long-standing expertise, particularly in microbiome analysis, its dual-platform capabilities, and its strong emphasis on customized bioinformatics support, which may not be as readily available from larger, more standardized providers.

More companies in Diagnostics & Precision Medicine →More companies in United States →